Cargando…

Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation

Spindle cell/sclerosing rhabdomyosarcoma (ssRMS) is a rare subtype of rhabdomyosarcoma, commonly harboring a gain-of-function L122R mutation in the muscle-specific master transcription factor MYOD1. MYOD1-mutated ssRMS is almost invariably fatal, and development of novel therapeutic approaches based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choo, Florence, Odinstov, Igor, Nusser, Kevin, Nicholson, Katelyn S., Davis, Lara, Corless, Christopher L., Stork, Linda, Somwar, Romel, Ladanyi, Marc, Davis, Jessica L., Davare, Monika A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory Press 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744497/ https://www.ncbi.nlm.nih.gov/pubmed/35012940 http://dx.doi.org/10.1101/mcs.a006140

Ejemplares similares

MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes
por: Rekhi, Bharat, et al.
Publicado: (2016)

Biological Role and Clinical Implications of MYOD1(L122R) Mutation in Rhabdomyosarcoma
por: Di Carlo, Daniela, et al.
Publicado: (2023)

MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma
por: Kikuchi, Ken, et al.
Publicado: (2013)

A blast from the past: ROS1 on the brain
por: Odintsov, Igor, et al.
Publicado: (2019)

Disruption of the MyoD/p21 Pathway in Rhabdomyosarcoma
por: Weintraub, Michael, et al.
Publicado: (1997)

NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors
por: Somwar, Romel, et al.
Publicado: (2020)

MoKCa database—mutations of kinases in cancer
por: Richardson, Christopher J., et al.
Publicado: (2009)

PI3KCA Mutations in Uterine Cervix Carcinoma
por: Voutsadakis, Ioannis A.
Publicado: (2021)

Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms
por: Nishikawa, G, et al.
Publicado: (2013)

GNAS Mutations in Pseudohypoparathyroidism Type 1a and Related Disorders
por: Lemos, Manuel C, et al.
Publicado: (2015)

Paratesticular Spindle Cell Rhabdomyosarcoma
por: Dey, Biswajit, et al.
Publicado: (2015)

GNAS and KRAS Mutations are Common in Intraductal Papillary Neoplasms of the Bile Duct
por: Sasaki, Motoko, et al.
Publicado: (2013)

MON-436 Clinical Phenotypes of GNAS Gene Mutations in Acromegalic Patients
por: Jung, Hyein, et al.
Publicado: (2019)

The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review
por: Lin, Yu-Lin, et al.
Publicado: (2020)

Rare Case of Pseudohypoparathyroidism With Normocalcemia Because of a Novel GNAS Mutation
por: Mangu, Goutami, et al.
Publicado: (2023)

A Novel Splicing Mutation of the GNAS Gene in a Patient with Pseudohypoparathyroidism Ia
por: Nakamura, Akie, et al.
Publicado: (2011)

Pseudohypoparathyroidism type 1a due to a novel mutation in the GNAS gene
por: Lemos, Manuel C., et al.
Publicado: (2015)

GNAS mutated thyroid carcinoma in a patient with Mc Cune Albright syndrome
por: Legrand, M.A., et al.
Publicado: (2020)

GNAS mutation is an unusual cause of primary adrenal insufficiency: a case report
por: Tong, Yajie, et al.
Publicado: (2022)

Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma
por: Pomella, Silvia, et al.
Publicado: (2021)

An Adult Case of Paratesticular Spindle Cell Rhabdomyosarcoma()
por: Delto, Joan C., et al.
Publicado: (2014)

Twist2 amplification in rhabdomyosarcoma represses myogenesis and promotes oncogenesis by redirecting MyoD DNA binding
por: Li, Stephen, et al.
Publicado: (2019)

Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum
por: Matsubara, A, et al.
Publicado: (2015)

Analysis of genetic alterations identifies the frequent mutation of GNAS in colorectal laterally spreading tumors
por: Nong, Yanying, et al.
Publicado: (2020)

Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei
por: Flatmark, Kjersti, et al.
Publicado: (2021)

Associations of GNAS Mutations with Surgical Outcomes in Patients with Growth Hormone-Secreting Pituitary Adenoma
por: Jung, Hyein, et al.
Publicado: (2021)

MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis
por: Lu, Daniel, et al.
Publicado: (2022)

CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG
por: Liu, Zhihui, et al.
Publicado: (2020)

Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas
por: Furukawa, Toru, et al.
Publicado: (2011)

GNAS Mutations Identify a Set of Right-Sided, RAS Mutant, Villous Colon Cancers
por: Fecteau, Ryan E., et al.
Publicado: (2014)

Identification of a novel GNAS mutation in a case of pseudohypoparathyroidism type 1A with normocalcemia
por: Long, Xiao-dan, et al.
Publicado: (2018)

Case report: An infantile lethal form of Albright hereditary osteodystrophy due to a GNAS mutation
por: Leclercq, Valérie, et al.
Publicado: (2018)

Case of Invasive Carcinoma Derived from Intraductal Papillary Mucinous Neoplasm Negative for GNAS Mutation
por: Fukuba, Nobuhiko, et al.
Publicado: (2019)

A case of ectopic pancreas of the stomach accompanied by intraductal papillary mucinous neoplasm with GNAS mutation
por: Nambu, Naoko, et al.
Publicado: (2021)

A Novel GNAS Mutation in a Patient with Ia Pseudohypoparathyroidism (iPPSD2) Phenotype
por: Gorbacheva, Anna, et al.
Publicado: (2023)

A2AR Expression and Immunosuppressive Environment Independent of KRAS and GNAS Mutations in Pseudomyxoma Peritonei
por: Kusamura, Shigeki, et al.
Publicado: (2023)

GNAS, PDE4D, and PRKAR1A Mutations and GNAS Methylation Changes Are Not a Common Cause of Isolated Early-Onset Severe Obesity Among Finnish Children
por: Loid, Petra, et al.
Publicado: (2020)

Association of Ataxia Telangiectasia Mutated (ATM) gene mutation/deletion with Rhabdomyosarcoma
por: Zhang, Peilin, et al.
Publicado: (2003)

SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function
por: Skrzypek, Klaudia, et al.
Publicado: (2018)

Actin-related protein 5 functions as a novel modulator of MyoD and MyoG in skeletal muscle and in rhabdomyosarcoma
por: Morita, Tsuyoshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ck8c70k6vhkm9rv2dna5o8eaui